Boehringer Ingelheim

AbbVie to Pay $595 Million for Boehringer Immunology Treatments
Bloomberg
Mon, 03/7/16 - 09:33 am
AbbVie
Boehringer Ingelheim
M&A
psoriasis
Crohn’s disease
asthma
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
Fierce Pharma Marketing
Wed, 02/3/16 - 05:30 pm
bloodthinners
Bristol-Myers Squibb
Eliquis
Xarelto
Pradaxa
Bayer
Pfizer
JNJ
Boehringer Ingelheim
Lilly, BI step closer to a new heart-risk marketing push on Jardiance
Fierce Pharma Marketing
Wed, 01/27/16 - 04:12 pm
Eli Lilly
Boehringer Ingelheim
diabetes
Jardiance
SGLT2 inhibitor
11 biopharma execs & experts look back on 2015: A record year for record-breaking
BioPharma Dive
Wed, 12/23/15 - 09:32 pm
Sanofi
Pfenex
inVentiv
Novocure
Accenture
Boehringer Ingelheim
Boehringer Ingelheim will hire 400, invest €500M in Vienna biologics operation
Fierce Pharma
Wed, 12/23/15 - 09:29 pm
Boehringer Ingelheim
drug manufacturing
Austria
Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis
Fierce Biotech
Mon, 12/21/15 - 10:50 am
Boehringer Ingelheim
breakthrough therapies
BI1482694
AstraZeneca
Clovis Oncology
non-small cell lung cancer
FDA approves cheaper version of top-selling diabetes drug
Yahoo/Reuters
Wed, 12/16/15 - 07:56 pm
FDA
diabetes
insulin
Lantus
Eli Lilly
Boehringer Ingelheim
Sanofi
Sanofi plans to reshape via $20 bln asset swap with Boehringer
Yahoo/Reuters
Tue, 12/15/15 - 09:58 am
Sanofi
Boehringer Ingelheim
Boehringer slashes its R&D budget with a new focus on collaboration
Fierce Biotech
Wed, 11/11/15 - 09:15 pm
Boehringer Ingelheim
R&D
Victoza Brings About No Effects To Help Control Heart Failure
Bidness, ETC
Tue, 11/10/15 - 03:54 pm
diabetes
heart failure
Jardiance
Victoza
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
Lilly diabetes drug cuts heart failure death, hospitalization -study
Yahoo/Reuters
Mon, 11/9/15 - 03:33 pm
Eli Lilly
Jardiance
diabetes
heart failure
Boehringer Ingelheim
Boehringer Ingelheim picks family member to lead it through tough times
Fierce Pharma
Fri, 11/6/15 - 03:32 pm
Boehringer Ingelheim
Boehringer expands its crowdsourced research to include psychiatric R&D
Fierce Biotech
Mon, 11/2/15 - 06:11 pm
Boehringer Ingelheim
R&D
crowdsourcing
Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share
Fierce Biotech
Sat, 10/17/15 - 03:30 pm
Boehringer Ingelheim
FDA
Pradaxa
bloodthinners
Praxbind
FDA's review of BI's Pradaxa was 'lax' and 'permissive,' watchdog claims
Fierce Pharma
Thu, 10/15/15 - 03:54 pm
FDA
Boehringer Ingelheim
Pradaxa
Boehringer's psoriasis drug beats Stelara in head-to-head Phase II
Fierce Biotech
Fri, 10/9/15 - 10:36 am
Boehringer Ingelheim
JNJ
Stelara
psoriasis
BI 655066
Payers want new guidelines, more data before easing access to diabetes' CV star Jardiance
Fierce Pharma
Mon, 10/5/15 - 05:52 pm
payer negotiation
Jardiance
diabetes
Eli Lilly
Boehringer Ingelheim
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
Fierce Pharma
Thu, 10/1/15 - 05:29 pm
Pradaxa
Xarelto
Eliquis
bloodthinners
Warfarin
drug safety
JNJ
Boehringer Ingelheim
Pfizer
Bristol-Myers Squibb
Boehringer finalizes team for crowdsourced COPD R&D initiative
Fierce Biotech
Thu, 09/24/15 - 07:14 pm
Boehringer Ingelheim
COPD
R&D
crowdsourcing
BioMed X
epigenetics
Eli Lilly Officially Puts Merck on Notice
Motley Fool
Tue, 09/22/15 - 09:50 am
Eli Lilly
Merck
Jardiance
diabetes
Boehringer Ingelheim
Januvia

Pages